scholarly journals Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

2012 ◽  
Vol 54 (10) ◽  
pp. 1413-1421 ◽  
Author(s):  
Alejandra Rosales ◽  
Johannes Hofer ◽  
Lothar-Bernd Zimmerhackl ◽  
Therese C. Jungraithmayr ◽  
Magdalena Riedl ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Hemolytic Uremic Syndrome ◽  
Enterohemorrhagic Escherichia Coli ◽  
Long Term Follow Up ◽  
Uremic Syndrome

scholarly journals Long-term follow-up of children with typical hemolytic uremic syndrome

Medicina ◽  
2015 ◽  
Vol 51 (3) ◽  
pp. 146-151
Author(s):  
Birutė Pundzienė ◽  
Diana Dobilienė ◽  
Rimantė Čerkauskienė ◽  
Renata Mitkienė ◽  
Aina Medzevičienė ◽  
...  
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Long Term Follow Up ◽  
Uremic Syndrome

Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis

2007 ◽  
Vol 22 (9) ◽  
pp. 1343-1347 ◽  
Author(s):  
Carlos J. Cobeñas ◽  
Laura F. Alconcher ◽  
Ana P. Spizzirri ◽  
Ricardo C. Rahman
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Long Term Follow Up ◽  
Uremic Syndrome

The hemolytic-uremic syndrome in California: A review of 28 nonheparinized cases with long-term follow-up

1973 ◽  
Vol 82 (2) ◽  
pp. 304-310 ◽  
Author(s):  
Bruce M. Tune ◽  
Thomas J. Leavitt ◽  
T. John Gribble
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Long Term Follow Up ◽  
Uremic Syndrome

scholarly journals Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods

PLoS ONE ◽  
2011 ◽  
Vol 6 (4) ◽  
pp. e19136 ◽  
Author(s):  
Romina J. Fernández-Brando ◽  
Leticia V. Bentancor ◽  
María Pilar Mejías ◽  
María Victoria Ramos ◽  
Andrea Exeni ◽  
...  
Keyword(s):  
Antibody Response ◽  
Hemolytic Uremic Syndrome ◽  
Shiga Toxins ◽  
Long Term Follow Up ◽  
Uremic Syndrome

Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome

2017 ◽  
Vol 32 (6) ◽  
pp. 1005-1011 ◽  
Author(s):  
Martin Kreuzer ◽  
Laura Sollmann ◽  
Stephan Ruben ◽  
Maren Leifheit-Nestler ◽  
Dagmar-Christiane Fischer ◽  
...  
Keyword(s):  
Endothelial Dysfunction ◽  
Hemolytic Uremic Syndrome ◽  
Long Term Follow Up ◽  
Uremic Syndrome

scholarly journals How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome

Blood ◽  
2000 ◽  
Vol 96 (4) ◽  
pp. 1223-1229 ◽  
Author(s):  
James N. George
Keyword(s):  
Renal Failure ◽  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Thrombotic Thrombocytopenic Purpura ◽  
Survival Rates ◽  
Thrombocytopenic Purpura ◽  
Long Term Follow Up ◽  
Uremic Syndrome

Abstract Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are, in adults, clinically and pathologically indistinguishable except for the severity of renal failure. They are best described as a single disorder, TTP-HUS, because the diagnostic evaluation and initial management are the same. Treatment with plasma exchange, available for more than 20 years, has dramatically altered the course of disease in adults with TTP-HUS. Plasma exchange has improved survival rates from 10% to between 75% and 92%, creating urgency for the initiation of treatment. This has resulted in decreased stringency of diagnostic criteria, which in turn has resulted in a broader spectrum of disorders for which the diagnosis of TTP-HUS is considered. Long-term follow-up has revealed increasing frequencies of relapse and of chronic renal failure. Although the increased survival rate is dramatic and recent advances in understanding the pathogenesis of these syndromes are remarkable, clinical decisions remain empirical. Therefore, the management decisions for patients with suspected TTP-HUS rely on individual experience and opinion, resulting in many different practice patterns. Multipractice clinical trials are required to define optimal management.

Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features

1997 ◽  
Vol 11 (2) ◽  
pp. 156-160 ◽  
Author(s):  
Francisco D. Spizzirri ◽  
Ricardo C. Rahman ◽  
Norma Bibiloni ◽  
Javier D. Ruscasso ◽  
Oscar R. Amoreo
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Prognostic Features ◽  
Long Term Follow Up ◽  
Uremic Syndrome

Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome

2004 ◽  
Vol 19 (11) ◽  
pp. 1241-1244 ◽  
Author(s):  
Laura De Petris ◽  
Alessandra Gianviti ◽  
Ugo Giordano ◽  
Armando Calzolari ◽  
Alberto E. Tozzi ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Hemolytic Uremic Syndrome ◽  
Long Term Follow Up ◽  
Uremic Syndrome

scholarly journals How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome

Blood ◽  
2000 ◽  
Vol 96 (4) ◽  
pp. 1223-1229 ◽  
Author(s):  
James N. George
Keyword(s):  
Renal Failure ◽  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Thrombotic Thrombocytopenic Purpura ◽  
Survival Rates ◽  
Thrombocytopenic Purpura ◽  
Long Term Follow Up ◽  
Uremic Syndrome

Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are, in adults, clinically and pathologically indistinguishable except for the severity of renal failure. They are best described as a single disorder, TTP-HUS, because the diagnostic evaluation and initial management are the same. Treatment with plasma exchange, available for more than 20 years, has dramatically altered the course of disease in adults with TTP-HUS. Plasma exchange has improved survival rates from 10% to between 75% and 92%, creating urgency for the initiation of treatment. This has resulted in decreased stringency of diagnostic criteria, which in turn has resulted in a broader spectrum of disorders for which the diagnosis of TTP-HUS is considered. Long-term follow-up has revealed increasing frequencies of relapse and of chronic renal failure. Although the increased survival rate is dramatic and recent advances in understanding the pathogenesis of these syndromes are remarkable, clinical decisions remain empirical. Therefore, the management decisions for patients with suspected TTP-HUS rely on individual experience and opinion, resulting in many different practice patterns. Multipractice clinical trials are required to define optimal management.

Sign in / Sign up

Export Citation Format

Share Document